Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in pediatrics

P Gal1, M D Reed, M C Nahata

  • 1Greensboro AHEC, Moses H. Cone Memorial Hospital, NC 27401.

The Annals of Pharmacotherapy
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel home-based method for preparing suspensions of anti-TB drugs.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Extemporaneously compounded liquid formulations of clofazimine.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Sugar and sugar-free liquid formulations of delamanid for patients with rifampicin-resistant TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Stable sugar and sugar-free suspensions of pretomanid.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Correspondence.

Clinical drug investigation·2016
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
See all related articles

Pediatric pharmacotherapy presents complex challenges, including genetic impacts on disease and ethical dilemmas in drug development. Ensuring children receive safe and effective treatments requires careful consideration of established and novel therapeutic strategies.

Area of Science:

  • Pharmacology and Therapeutics
  • Pediatric Medicine
  • Genetics and Personalized Medicine

Background:

  • Pediatric pharmacotherapy faces significant challenges, including ethical considerations in drug development and the impact of genetic variations on treatment efficacy.
  • The inclusion of pediatric populations in clinical trials remains a contentious issue, impacting the availability of evidence-based treatments for children.
  • Balancing established therapies with novel approaches is crucial for optimizing pediatric healthcare outcomes.

Purpose of the Study:

  • To highlight key challenges and advancements in pediatric pharmacotherapy.
  • To discuss the role of microtechnologies and genetic evaluations in understanding disease and guiding treatment.
  • To address ethical dilemmas and clinical considerations in pediatric drug development and application.

Related Experiment Videos

Main Methods:

  • Review of current literature and emerging research in pediatric pharmacotherapy.
  • Discussion of technological advancements, such as polymerase chain reaction (PCR), for genetic analysis.
  • Analysis of ethical and clinical issues surrounding pediatric patient inclusion in drug trials.

Main Results:

  • Genetic factors significantly influence disease presentation and drug response in children, necessitating personalized treatment strategies.
  • Ethical debates persist regarding the inclusion of pediatric subjects in drug development and marketing trials.
  • The importance of well-established therapies should be maintained alongside the exploration of new treatment modalities.

Conclusions:

  • Addressing the complexities of pediatric pharmacotherapy requires a multidisciplinary approach, integrating genetic insights and ethical considerations.
  • Future research and clinical practice should focus on evidence-based interventions that benefit infants, children, and adolescents.
  • Continued dialogue and research are essential for advancing the safe and effective use of medications in pediatric populations.